Apyx Medical Corporation

APYX Healthcare Medical Devices

Apyx Medical Corporation’s revenue for fiscal 2025 (year ended December 2025) was $52.8 million, up 9.86% from fiscal 2024. In the quarter to June 2026, revenue grew 22.1%, EPS grew 22.2%, free cash flow fell 137.4% and total debt rose 2.74%, each against the same quarter a year earlier.

2.55 0.01 −0.39%
Market cap
$107.8M
P/E
0.0×
Fwd P/E
−16.0×
Dividend yield
—
F-score
4/9
Altman Z
1.10
Beneish M
−2.63
Dividend safety
n/a

Apyx Medical Corporation (APYX) P/E ratio

Alert me on P/E ratio

Apyx Medical Corporation has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 4.7× (August 2019) — the current reading is the lowest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 3.4× 0.00%
FY2017 3.4× 0.00%
FY2016 3.4× 0.00%

Quarterly newest first

Period P/E ratio Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
42 more quarters

Against its own ten years

Low 0.0× High 4.7×
Ten-year median 0.0×
Current reading's percentile 90

P/E ratio against peers

Company P/E ratio
QTRX Quanterix Corporation compare n/m
HYPR Hyperfine, Inc. compare n/m
OWLT Owlet, Inc. compare n/m
SERA Sera Prognostics, Inc. compare n/m
MXCT MaxCyte, Inc. compare n/m
LUCD Lucid Diagnostics Inc. compare n/m
ZOMDF Zomedica Corp. compare n/m
LUNG Pulmonx Corporation compare n/m
APYX Apyx Medical Corporation n/m
Medical Devices industry median 23.2×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on APYX